1/9/2023CDE Issues the List of Reference Formulations for GQCE Studies (63rd B...

1/9/2023Shionogi to Diversify Sourcing of APIs and Raw Materials Away from Ch...

1/9/2023Simnova and Orna Thera Collaborate to Advance Orna's Next Gen Circular...

1/9/2023Big Pharma Preferred by Foreign Investors as China Reopens, Appetite F...

1/6/2023Top The Chinese Pharma In-licensing Deals in 2022 (PharmCube)

1/6/2023Top Ten Chinese Biopharma Out-licensing Deals in 2022 (PharmCube)

1/6/2023Pfizer Reportedly in Talks with China over Paxlovid Generic

1/6/2023CDE Solicits Comments on the Technical Guidelines for R&D of TCM Impro...

1/6/2023CDE Solicits Comments on Draft Implementation Proposal and Chinese Tra...

1/6/2023CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines M11

1/6/2023China Issues Two New Policies on BMI Reimbursement of Covid Hospitaliz...

1/6/2023Latest Cancer Drugmaker's IPO Mints China's Latest Billionaire

1/6/2023Recent Executive Moves

1/6/2023Drug R&D and Product Registration News Digest January 2023 (1)

1/5/2023GSK and WuXi Biologics Enter License Deal on Multiple Novel Bi- & Mult...

1/5/2023CANbridge Consolidates Gene Therapy Portfolio by Exercising License Op...

1/5/2023NMPA Holds National Drug Regulatory Conference in Beijing

1/5/20232022 NRDL Access Negotiation Reinitiated with Industry Hoping for "Mod...

1/5/2023Adcendo ApS Announces License Agreement with Duality Biologics on Next...

1/5/2023Aurisco to Build Oligonucleotides Manufacturing Facility in China

1/5/2023Shionogi Covid Drug Xocova May Get Chinese Approval in March

1/5/202320 Promising New Drugs Anticipated To Be Approved in China 2023 (Pharm...

1/5/2023FDA's Wang Yaning: Anti-Aβ Therapies Can Delay Progression of AD (Pha...

1/4/2023Biocytogen and Hansoh Pharma Enter Antibody License Deal for China

1/4/2023NHC and SATCM Announce Action Plan for the Overall Pain Management Tri...

1/3/2023Fosun Pharma and Henlius Entered into an Exclusive License Agreement f...

1/3/2023CDE Solicits Comments on the Technical Guidelines for R&D of Oral Comp...

1/3/2023China Turns Down EU Offer of Free COVID Vaccines

1/3/2023Legend Biotech's NDA for Ciltacabtagene Autoleucel (Cilta-Cel) Accepte...

12/30/2022Merck's COVID Drug Molnupiravir Conditionally Approved in China

Page:116/775 Total number of articles:23234: [First][<<] [114] [115] [116] [117] [118] [>>] [End]